Unfortunately, there is amistake in the section Results, Clinical safety. While the text states that “no severe AEs were reported”, in fact one severe AE was reported in the iomeprol group (one severe injection site pain assessed as possibly related to contrast agent), as shown in Table 5. In addition, the name of the author Jean-François Paul was rendered incorrectly in the original publication but has since been corrected. The authors apologize for these mistakes
In the article titled Changes in Ocular Blood Flow after Ranibizumab Intravitreal Injection for Diab...
Following publication of the original article [1], the authors reported that there was a mistake in ...
Correction to: Scientific Reports https://doi.org/10.1038/srep32062, published online 31 August 201
A technical error led to incorrect rendering of the author group in this article. The correct author...
The original version of this article, published on 05 September 2019, unfortunately contained a mist...
International audienceThe originally published article [1] unfortunately contained several mistakes,...
The authors would like to inform that in the original publication two rows stating ‘RT alone’ in Tab...
The original version of this article, published on 05 September 2019, unfortunately contained a mist...
A technical error led to incorrect rendering of the author group in this article. The correct author...
The authors sincerely regret that Dr. Michael David was not included in the list of authors on the a...
The original version of this article, published on 19 March 2018, unfortunately contained a mistake....
Figure Legend In the original publication [1], there was a mistake in the legend for Figure 8. Value...
Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation develope...
This article is a correction to: Comparison of 3DCRT and IMRT out-of-field doses in pediatric patien...
In the original article, there was an error. Incorrect reference numbers and authors names were cite...
In the article titled Changes in Ocular Blood Flow after Ranibizumab Intravitreal Injection for Diab...
Following publication of the original article [1], the authors reported that there was a mistake in ...
Correction to: Scientific Reports https://doi.org/10.1038/srep32062, published online 31 August 201
A technical error led to incorrect rendering of the author group in this article. The correct author...
The original version of this article, published on 05 September 2019, unfortunately contained a mist...
International audienceThe originally published article [1] unfortunately contained several mistakes,...
The authors would like to inform that in the original publication two rows stating ‘RT alone’ in Tab...
The original version of this article, published on 05 September 2019, unfortunately contained a mist...
A technical error led to incorrect rendering of the author group in this article. The correct author...
The authors sincerely regret that Dr. Michael David was not included in the list of authors on the a...
The original version of this article, published on 19 March 2018, unfortunately contained a mistake....
Figure Legend In the original publication [1], there was a mistake in the legend for Figure 8. Value...
Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation develope...
This article is a correction to: Comparison of 3DCRT and IMRT out-of-field doses in pediatric patien...
In the original article, there was an error. Incorrect reference numbers and authors names were cite...
In the article titled Changes in Ocular Blood Flow after Ranibizumab Intravitreal Injection for Diab...
Following publication of the original article [1], the authors reported that there was a mistake in ...
Correction to: Scientific Reports https://doi.org/10.1038/srep32062, published online 31 August 201